Stay updated on PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial

Sign up to get notified when there's something new on the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.5, replacing Revision: v3.5.4. This indicates a minor update to the study record page without altering core content.
    Difference
    0.1%
    Check dated 2026-06-05T21:59:01.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.4, indicating deployment of a new page version that replaces the previous v3.5.3.
    Difference
    0.1%
    Check dated 2026-05-15T14:34:23.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
     ClinicalTrials.gov’s study page revision label was updated to a newer version (v3.5.3) from the previous one (v3.5.2).
    Difference
    0.1%
    Check dated 2026-04-24T05:46:46.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:33:05.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    - Cosmetic UI adjustments observed (overlay elements and layout tweaks). Core study content such as eligibility criteria, interventions, and primary outcomes remains unchanged.
    Difference
    0.1%
    Check dated 2026-03-26T11:37:37.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.5.0' was added and the previous label 'Revision: v3.4.3' was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:49:37.000Z thumbnail image

Stay in the know with updates to PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PEMBRACA: Pembrolizumab+Carboplatin in Breast Cancer Antigens Clinical Trial page.